TKNO News and Press, Alpha Teknova Inc. From 03/11/24

Full year 2023 total revenue was $36.7 million, down 11% year-over-year Achieved 36% annual growth in the number of Clinical Solutions customers in 2023 Company provides 2024 revenue guidance of $35-38 million HOLLISTER, Calif., March 11, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, ...

Volcon Inc. (VLCN) is expected to report for Q4 2023 Tenaga Nasional Bhd ADR (TNABY) is expected to report for quarter end 2023-12-31 Hesai Group (HSAI) is expected to report for Q4 2023 Intrusion Inc. (INTZ) is expected to report $-0.14 for Q4 2023 Eliem Therapeutics Inc (ELYM) i...

HOLLISTER, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Compan...

2023-11-11 05:01:10 ET Alpha Teknova, Inc. (TKNO) Q3 2023 Earnings Conference Call November 09, 2023, 05:30 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Stephen Gunstream - President & Chief Executive Officer Matthew Lowell -...

2023-11-09 16:17:08 ET More on Alpha Teknova Alpha Teknova, Inc. (TKNO) Q2 2023 Earnings Call Transcript Alpha Teknova to sell 1.086M shares at $1.85 in registered direct offering Seeking Alpha’s Quant Rating on Alpha Teknova Historical earnings data f...

Raised $22.9 million of equity capital, paid down $10.0 million of long-term debt Third quarter 2023 total revenue was $8.2 million, down 24% from prior year Expect 2023 revenue at the low end of previously announced guidance range of $37-40 million HOLLISTER, Calif., Nov. 09, 2...

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

Alpha Teknova Inc. (TKNO) is expected to report $-0.28 for Q3 2023

HOLLISTER, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Compan...

2023-10-25 17:01:55 ET More on Alpha Teknova Alpha Teknova to sell 1.086M shares at $1.85 in registered direct offering Seeking Alpha’s Quant Rating on Alpha Teknova Historical earnings data for Alpha Teknova Financial information for Alpha Teknova ...